Christchurch, New Zealand Clinical Trials

A listing of Christchurch, New Zealand clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 56 clinical trials
Featured trial
Evaluating the Psychometric Properties of Three Clinical Trial Outcome Measures for Rett Syndrome

Evaluating the Psychometric Properties of Three Clinical Trial Outcome Measures for Rett Syndrome: The purpose of this research study is to document the psychometric properties of three non-invasive, clinic-friendly, and quantifiable outcome measures reflecting pathologically- and clinically-relevant symptoms of Rett Syndrome (RTT). Despite several ongoing or pending clinical trials for …

Online studies
Gillette Children's Hospital
(online study) Contact site
  • 11 views
  • 30 Jun, 2022
  • 1 location
  • Online study
Featured trial
Repetitive Behavior in Early Childhood

The University of Minnesota is seeking family caregivers of children between the ages of 2 and 6 with and without developmental delays to respond to a survey. The purpose of this survey is to learn more about the development of repetitive behavior in early childhood. The survey is fully virtual …

Accepts healthy volunteers
Online studies
University of Minnesota, Department of Psychology
(online study) Contact site
  • 19 views
  • 30 Jun, 2022
  • 1 location
  • Online study
Featured trial
Caregiver-Provided Life Review for Persons with Dementia in Care Facilities

This study, Caregiver-Provided Life Review (C-PLR) is created based on Life Review therapy. It is for persons living with early-stage dementia along with mild depressive symptoms who are 65 years or older, community-dwellers or the residents of senior housing, independent or assisted living facilities conducted by their family members (18 …

depression
Online studies
Accepts healthy volunteers
dementia
Online Study Center
(online study) Contact site
  • 503 views
  • 05 Jul, 2022
  • 1 location
  • Online study
Objective, Passive Assessment of LRRK2 Carriers (OPAL)

This study is currently only open to active participants in the University of Rochester’s VALOR-PD study. The goal of this project is to identify objective, sensitive, and convenient measures for assessing early signs of Parkinson's disease in an at-risk population at home. We will do so by using a wireless …

movement disorder
Online studies
University of Rochester
(online study) Contact site
  • 8 views
  • 12 May, 2022
  • 1 location
  • Online study
EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer (EXPERT)

This is a randomised, phase III, non-inferiority trial evaluating radiation therapy versus observation following breast conserving surgery and planned endocrine therapy in patients with stage I breast cancer of luminal A subtype defined using the Prosigna (PAM50) Assay.

Christchurch Hospital
 (0.2 away) Contact site
  • 733 views
  • 04 May, 2022
  • +55 other locations
SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT2)

SELECT 2 evaluates the efficacy and safety of endovascular thrombectomy compared to medical management alone in acute ischemic stroke patients due to a large vessel occlusion in the distal ICA and MCA M1 who have large core on either CT (ASPECTS: 3-5) or advanced perfusion imaging ([rCBF<30%] on CTP or …

Christchurch Hospital
 (0.2 away) Contact site
  • 36 views
  • 14 May, 2022
  • +27 other locations
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC) (AMPLITUDE)

The purpose of the study is to determine if the combination of niraparib with Abiraterone Acetate (AA) plus prednisone compared with AA plus prednisone in participants with deleterious germline or somatic Homologous Recombination Repair (HRR) gene-mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC) provides superior efficacy in improving radiographic progression-free survival (rPFS).

Dunedin Hospital
 (192.0 away) Contact site
  • 87 views
  • 09 Jun, 2022
  • +334 other locations
Study of ARO-APOC3 in Adults With Mixed Dyslipidemia (MUIR)

Participants who have met all protocol eligibility criteria will be randomly assigned to treatment (ARO-APOC3 or placebo) in a double-blind fashion and will be evaluted for safety and efficacy over 48 weeks. Participants will be counseled to remain on a specified diet throughout the study, as recommended by the Investigator …

Southern Clinical Trials Christchurch
 (1.6 away) Contact site
  • 0 views
  • 14 Jun, 2022
  • +29 other locations
Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL) (BRUIN-MCL-321)

This is a study for participants with a type of blood cancer called mantle cell lymphoma (MCL). The main purpose is to compare pirtobrutinib (LOXO-305) to other drugs that work in a similar way that have already been approved by the United States Food and Drug Administration (US FDA). Participation …

measurable disease
ibrutinib
cancer
btk inhibitor
acalabrutinib
Christchurch Hospital
 (0.2 away) Contact site
  • 27 views
  • 15 Jun, 2022
  • +158 other locations
A Study of MK-1084 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With KRASG12C Mutant Advanced Solid Tumors (MK-1084-001)

This is a study evaluating the efficacy, safety, and pharmacokinetics of MK-1084 in participants with advanced solid tumors with identified kirsten rat sarcoma viral oncogene homolog G12C (KRASG12C) mutation and MK-1084 plus pembrolizumab in participants with first line (1L) non-small cell lung cancer (NSCLSC) with identified KRASG12C mutation.

New Zealand Clinical Research (Christchurch) ( Site 0004)
 (0.2 away) Contact site
  • 2 views
  • 28 Jun, 2022
  • +20 other locations